Evaluation of 4-borono-2-18F-fluoro-L-phenylalanine-fructose as a probe for boron neutron capture therapy in a glioma-bearing rat model

Journal of Nuclear Medicine

Volumn 45, Issue 2, 2004, Pages 302-308

  Wang, Hsin Ell ^a   Liao, Ai Ho ^a   Deng, Win Ping ^b   Chang, Pi Fang ^a   Chen, Jyh Cheng ^a   Chen, Fu Du ^a   Liu, Ren Shen ^c   Lee, Jin Shin ^a   Hwang, Jeng Jong ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

4 borono 2 18F fluoro L phenylalanine fructose; Boron neutron capture therapy; F98 glioma; Microautoradiography; PET

Indexed keywords

4 BORONO 2 FLUORO PHENYLALANINE FRUCTOSE F 18; 4 BORONOPHENYLALANINE; ACETYL HYPOFLUORITE F 18; RADIOPHARMACEUTICAL AGENT; TRIFLUOROACETIC ACID; UNCLASSIFIED DRUG; 4 BORONO 2 FLUOROPHENYLALANINE; 4-BORONO-2-FLUOROPHENYLALANINE; BORON DERIVATIVE; DIAGNOSTIC AGENT; DRUG DERIVATIVE; FLUORINE; FRUCTOSE; PHENYLALANINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG DISTRIBUTION; GLIOMA; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ISOTOPE LABELING; MALE; NEUTRON CAPTURE THERAPY; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RAT; ANIMAL; AUTORADIOGRAPHY; BRAIN TUMOR; COMPUTER ASSISTED EMISSION TOMOGRAPHY; FISCHER 344 RAT; SCINTISCANNING; TISSUE DISTRIBUTION;

ANIMALS; AUTORADIOGRAPHY; BORON COMPOUNDS; BORON NEUTRON CAPTURE THERAPY; BRAIN NEOPLASMS; FLUORINE RADIOISOTOPES; FRUCTOSE; GLIOMA; MALE; PHENYLALANINE; RATS; RATS, INBRED F344; TISSUE DISTRIBUTION; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 1542399587     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Slatkin DN. A history of boron neutron capture therapy of brain tumors: postulation of a brain radiation dose tolerance limit. Brain. 1991;114:1609-1629.
2. Barth RF, Soloway AH, Fairchild RO, Brugger RM. Boron neutron capture therapy for cancer: realities and prospects. Cancer. 1992;70:2995-3007.
3. Coderre JA, Chanana AD, Joel DD, et al. Biodistribution of boronophenylalanine in patients with glioblastoma multiforme: boron concentration correlates with tumor cellularity. Radiat Res. 1998;149:163-170.
4. Locher GL. Biological effects and therapeutic possibilities of neutrons. AJR. 1936;36:1-13.
5. Hatanaka H, Nakagawa Y. Clinical results of long surviving brain tumor patients who underwent boron neutron capture therapy. Int J Radiat Oncol Biol Phys. 1994;28:1061-1066.
6. Diaz AZ. Assessment of the results from the phase I/II boron neutron capture therapy trials at the Brookhaven National Laboratory from a clinician's point of view. J Neurooncol. 2003;62:101-109.
7. Hideghety K, Sauerwein W, Haselsberger K, et al. Postoperative treatment of glioblastoma with BNCT at the Petten irradiation facility. Strahlenther Onkol. 1999;175(suppl 2):111-114.
8. Soloway AH, Tjarks W, Barnum BA, et al. The chemistry of neutron capture therapy. Chem Rev. 1998;98:1515-1562.
9. Yoshino K, Suzuki A, Mori Y, et al. Improvement of solubility of p-boronophenylalanine by complex formation with monosaccharides. Strahlenther Onkol. 1989;165:127-129.
10. 10B-BPA-fructose complex. In: Allen BJ, Moore DE, Harrington BV, eds. Progress in Neutron Capture Therapy for Cancer. New York, NY: Plenum Press; 1992:421-424.
11. Imahori Y, Ueda S, Ohmori Y, et al. Fluorine-18-labeled fluoroboronophenylalanine PET in patients with glioma. J Nucl Med. 1998;39:325-333.
12. Jewett DM, Potocki JF, Ehrenkaufer RE. A gas-solid phase microchemical method for the synthesis of acetyl hypofluorite. J Fluor Chem. 1984;38:477-484.
13. Imahori Y, Ueda S, Ohmori Y, et al. Positron emission tomography-based boron neutron capture therapy using boronophenylalanine for high-grade gliomas: Part I. Clin Cancer Res. 1998;4:1825-1832.
14. 18F]fluoro-L-phenylalanine. Melanoma Res. 1992;2:171-179.
15. Coderre JA, Elowitz E, Chadha M, Bergland R, Capala J, Joel DD. Boron neutron capture therapy of glioblastoma multiforme using p-boronophenylalanine and epithermal neutrons: trial design and early clinical results. J Neurooncol. 1997;33:141-152.
16. 18F]fluoro-D,L-phenylalanine: a target compound for PET and boron neutron capture therapy. Appl Radiat Isot. 1991;42:325-328.